These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 12395915

  • 1. Temozolomide in second-line treatment after prior nitrosurea-based chemotherapy in glioblastoma multiforme: experience from a Portuguese institution.
    Teixeira MM, Garcia I, Portela I, Cernuda M, Oliveira C, Albano J, Lima L.
    Int J Clin Pharmacol Res; 2002; 22(1):19-22. PubMed ID: 12395915
    [Abstract] [Full Text] [Related]

  • 2. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
    Chamberlain MC, Tsao-Wei DD.
    Cancer; 2004 Mar 15; 100(6):1213-20. PubMed ID: 15022289
    [Abstract] [Full Text] [Related]

  • 3. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE, Postma TJ.
    Ned Tijdschr Geneeskd; 2005 Jun 18; 149(25):1376-8. PubMed ID: 15997689
    [Abstract] [Full Text] [Related]

  • 4. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L, Vitanovics D, Afra D.
    Ideggyogy Sz; 2004 Nov 20; 57(11-12):394-9. PubMed ID: 15662767
    [Abstract] [Full Text] [Related]

  • 5. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
    Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA.
    Br J Cancer; 2000 Sep 20; 83(5):588-93. PubMed ID: 10944597
    [Abstract] [Full Text] [Related]

  • 6. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R.
    No To Shinkei; 2006 Dec 20; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract] [Full Text] [Related]

  • 7. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Brandes AA, Tosoni A, Basso U, Reni M, Valduga F, Monfardini S, Amistà P, Nicolardi L, Sotti G, Ermani M.
    J Clin Oncol; 2004 Dec 01; 22(23):4779-86. PubMed ID: 15570079
    [Abstract] [Full Text] [Related]

  • 8. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, Prados MD, Bruner JM, Chang SM, Kyritsis AP, Gleason MJ, Hess KR.
    Clin Cancer Res; 2000 Oct 01; 6(10):3878-84. PubMed ID: 11051233
    [Abstract] [Full Text] [Related]

  • 9. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R, Basu A, Gupta T, Munshi A, Menon H, Sarin R, Goel A.
    Br J Neurosurg; 2007 Dec 01; 21(6):583-7. PubMed ID: 18071985
    [Abstract] [Full Text] [Related]

  • 10. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.
    Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L, Wannenmacher MM, Debus J.
    Strahlenther Onkol; 2005 Jun 01; 181(6):372-7. PubMed ID: 15925979
    [Abstract] [Full Text] [Related]

  • 11. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A.
    Anticancer Res; 2003 Jun 01; 23(6D):5159-64. PubMed ID: 14981983
    [Abstract] [Full Text] [Related]

  • 12. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
    Aoki T, Mizutani T, Ishikawa M, Sugiyama K, Hashimoto N.
    Int J Clin Oncol; 2003 Oct 01; 8(5):301-4. PubMed ID: 14586755
    [Abstract] [Full Text] [Related]

  • 13. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
    Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P.
    J Clin Oncol; 2005 Apr 01; 23(10):2372-7. PubMed ID: 15800329
    [Abstract] [Full Text] [Related]

  • 14. Temozolomide and other potential agents for the treatment of glioblastoma multiforme.
    Nagasawa DT, Chow F, Yew A, Kim W, Cremer N, Yang I.
    Neurosurg Clin N Am; 2012 Apr 01; 23(2):307-22, ix. PubMed ID: 22440874
    [Abstract] [Full Text] [Related]

  • 15. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.
    Chinot OL, Barrie M, Frauger E, Dufour H, Figarella-Branger D, Palmari J, Braguer D, Hoang-Xuan K, Moktari K, Peragut JC, Martin PM, Grisoli F.
    Cancer; 2004 May 15; 100(10):2208-14. PubMed ID: 15139066
    [Abstract] [Full Text] [Related]

  • 16. Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study.
    Brandes AA, Ermani M, Basso U, Amistà P, Berti F, Scienza R, Rotilio A, Pinna G, Gardiman M, Monfardini S.
    Ann Oncol; 2001 Feb 15; 12(2):255-7. PubMed ID: 11300334
    [Abstract] [Full Text] [Related]

  • 17. Temozolomide (Temodal) for treatment of primary brain tumours.
    MacConnachie AM.
    Intensive Crit Care Nurs; 2000 Feb 15; 16(1):59-60. PubMed ID: 10790718
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.
    Chinot OL, Honore S, Dufour H, Barrie M, Figarella-Branger D, Muracciole X, Braguer D, Martin PM, Grisoli F.
    J Clin Oncol; 2001 May 01; 19(9):2449-55. PubMed ID: 11331324
    [Abstract] [Full Text] [Related]

  • 19. [What type of adjuvant chemotherapy should be proposed for the initial treatment of glioblastoma?].
    Ducray F, Honnorat J.
    Presse Med; 2007 Sep 01; 36(9 Pt 2):1249-54. PubMed ID: 17350791
    [Abstract] [Full Text] [Related]

  • 20. Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.
    Scoccianti S, Detti B, Sardaro A, Iannalfi A, Meattini I, Leonulli BG, Borghesi S, Martinelli F, Bordi L, Ammannati F, Biti G.
    Anticancer Drugs; 2008 Jul 01; 19(6):613-20. PubMed ID: 18525321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.